{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":33,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":33,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"8cebc2dd487b","filters":{"venue":"Current Hematologic Malignancy Reports"}},"results":[{"id":"W2287622513","doi":"10.1007/s11899-016-0313-6","title":"Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CARE Canada","funders":"National Cancer Institute","keywords":"Medicine; Young adult; Cancer; Breast cancer; Incidence (geometry); Population; Social media; Oncology; Internal medicine; Pediatrics; Gerontology","authors":[{"name":"Miguel‐Angel Perales","is_ca":false},{"name":"Emily K. Drake","is_ca":true},{"name":"Naveen Pemmaraju","is_ca":false},{"name":"William A. Wood","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05691916317588371,"gpt":0.3565261188265781,"spread":0.2996069556506945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002962205,0.0003039507,0.0005651275,0.001415599,0.000323558,0.001022158,0.000300396,0.0007008641,0.002247344],"category_scores_gemma":[0.001517566,0.0001420988,0.0005821752,0.001704075,0.0002708234,0.0007886915,0.0005229942,0.000827527,0.0001977855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003792443,"about_ca_system_score_gemma":0.000938474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003366982,"about_ca_topic_score_gemma":0.01002492,"domain_scores_codex":[0.9998172,0.00005018553,0.00003386699,0.00002535258,0.00005392075,0.0000196254],"domain_scores_gemma":[0.9992192,0.0004829758,0.0001938328,0.000005966868,0.00004976168,0.00004831631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001555382,0.0001836729,0.02424232,0.04932582,0.0008890674,0.0009689999,0.0006854595,0.0001176698,0.0003420302,0.001495879,0.01859938,0.9029943],"study_design_scores_gemma":[0.00008148176,0.0003015758,0.1109699,0.09870923,0.003964941,0.009447373,0.004186405,0.0001450057,0.0005292104,0.001408512,0.7701572,0.00009912523],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001775843,0.9967363,0.00001213315,0.0004149381,0.0001198091,0.00000413032,0.00003969994,0.000001287918,0.0008957773],"genre_scores_gemma":[0.009166468,0.9900934,0.00004711582,0.0002739422,0.0001490296,0.000005956347,0.00003533533,4.389864e-7,0.0002283128],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003366982,"threshold_uncertainty_score":0.007518053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2409124043","doi":"10.1007/s11899-016-0333-2","title":"Value Based Care and Patient-Centered Care: Divergent or Complementary?","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Value (mathematics); Health care; Quality (philosophy); Incentive; Medicine; Preference; Payment; Value-Based Purchasing; Reimbursement; Nursing; Family medicine; Business; Computer science; Economics; Microeconomics","authors":[{"name":"Eric Tseng","is_ca":true},{"name":"Lisa K. Hicks","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09273398251352287,"gpt":0.3165248023298274,"spread":0.2237908198163046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00781749,0.0006626358,0.002546113,0.002387814,0.0004992328,0.00593501,0.001790218,0.003466504,0.006503638],"category_scores_gemma":[0.01522959,0.0003533921,0.0009530844,0.006108145,0.005033868,0.005502454,0.00228521,0.005000553,0.0007660617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003706068,"about_ca_system_score_gemma":0.007837328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004945904,"about_ca_topic_score_gemma":0.008641502,"domain_scores_codex":[0.9966553,0.001567415,0.0003076241,0.0002920819,0.0009741207,0.0002034685],"domain_scores_gemma":[0.9819449,0.01412431,0.001639419,0.0003001217,0.00152,0.0004712699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000152602,0.0001293041,0.0016391,0.02265924,0.0005177996,0.0001195696,0.0007217409,0.0005129667,0.0001115036,0.1425157,0.02707866,0.8038418],"study_design_scores_gemma":[0.0001604424,0.0001823622,0.008363049,0.08133423,0.000657896,0.001000787,0.003083454,0.0005395086,0.0001759898,0.1664154,0.737973,0.0001138649],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000232545,0.9903281,0.0002060994,0.007511237,0.0003022328,0.0000033206,0.00001068156,0.000001769504,0.001404039],"genre_scores_gemma":[0.008347718,0.9858504,0.0004206651,0.0038401,0.001250012,0.00001292824,0.00001922044,0.000003502266,0.0002554337],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00781749,"threshold_uncertainty_score":0.04134333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024403341","doi":"10.1007/s11899-013-0163-4","title":"Hodgkin Lymphoma in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pregnancy; Vinblastine; Lymphoma; Intensive care medicine; Disease; Hodgkin lymphoma; Chemotherapy; Internal medicine; Pediatrics; Obstetrics","authors":[{"name":"Veronika Bachanová","is_ca":false},{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03098564659025149,"gpt":0.3045995390588377,"spread":0.2736138924685862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003107323,0.0001309919,0.0001169928,0.0009664739,0.0005663016,0.0006651087,0.00018574,0.0005010241,0.003044514],"category_scores_gemma":[0.002579557,0.0001623285,0.00009632793,0.0007022972,0.0003201774,0.0005007152,0.0003638101,0.0005406095,0.0004691466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003898455,"about_ca_system_score_gemma":0.0006919248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002914666,"about_ca_topic_score_gemma":0.001795774,"domain_scores_codex":[0.9997972,0.00004684797,0.00002548355,0.000020526,0.00002835336,0.00008164177],"domain_scores_gemma":[0.9995918,0.0001312154,0.0001145037,0.00003129544,0.0000316529,0.00009954069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000234112,0.0002134034,0.8508834,0.0001074779,0.00002547287,0.08008247,0.001054687,0.0001623773,0.001622702,0.002148621,0.004157082,0.0593082],"study_design_scores_gemma":[0.00004363696,0.0003241609,0.524789,0.0006039463,0.0001237261,0.4232797,0.003586223,0.0004845067,0.002301132,0.002792104,0.04163841,0.00003346266],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9078132,0.02655709,0.0005073177,0.006861989,0.0003701682,0.00004676998,0.0003135015,0.00006105076,0.05746878],"genre_scores_gemma":[0.983408,0.01273111,0.0001605428,0.0005788569,0.0003251666,0.00001180805,0.0001326194,0.000004558499,0.002647316],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003044514,"threshold_uncertainty_score":0.01018494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1946581526","doi":"10.1007/s11899-015-0286-x","title":"Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":51,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Aurora Research Institute; American Association for Cancer Research","keywords":"Social media; Microblogging; Workflow; Public relations; Internet privacy; Hematologist; Health care; Medicine; Medical education; World Wide Web; Computer science; Internal medicine; Political science","authors":[{"name":"Michael A. Thompson","is_ca":false},{"name":"Navneet S. Majhail","is_ca":false},{"name":"William A. Wood","is_ca":false},{"name":"Miguel‐Angel Perales","is_ca":false},{"name":"Mélanie Chaboissier","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4678624804527811,"gpt":0.5264026431069447,"spread":0.05854016265416362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0008162009,0.0005627496,0.0007371388,0.002380642,0.0005674363,0.001887497,0.0005997882,0.002255599,0.007886132],"category_scores_gemma":[0.00457828,0.0002140406,0.0007226632,0.002133592,0.0005109181,0.002302105,0.001279361,0.001853771,0.001346162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007117568,"about_ca_system_score_gemma":0.001981107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002459113,"about_ca_topic_score_gemma":0.008529051,"domain_scores_codex":[0.9994492,0.0001964316,0.00007401748,0.00005989798,0.0001671044,0.00005330679],"domain_scores_gemma":[0.9968075,0.002174704,0.0004930266,0.00002933558,0.0002582498,0.0002372438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007705516,0.00008166777,0.002509732,0.01860902,0.0001605249,0.0002732317,0.000375483,0.00005290013,0.000236207,0.001270968,0.0836203,0.8927329],"study_design_scores_gemma":[0.0000396289,0.0001237006,0.01278789,0.04480821,0.0004911547,0.001721367,0.001896754,0.0001223084,0.0002673937,0.001294029,0.9363925,0.00005506951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009287047,0.9885885,0.00006788696,0.005663387,0.001305004,0.00001215673,0.00007385263,0.00001256001,0.003348046],"genre_scores_gemma":[0.008044049,0.984703,0.0002219299,0.002818802,0.002137099,0.00002176049,0.00009904848,0.000005701368,0.001948618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9981125,"threshold_uncertainty_score":0.02638179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2801721440","doi":"10.1007/s11899-018-0449-7","title":"Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Oncology; Disease; Tyrosine kinase; Imatinib mesylate; Tyrosine-kinase inhibitor; Internal medicine; Myeloid leukemia; Toxicity; Pharmacology; Intensive care medicine; Cancer","authors":[{"name":"James A. Kennedy","is_ca":true},{"name":"Gabriela Hobbs","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07998761122677826,"gpt":0.4216340902875697,"spread":0.3416464790607914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009608223,0.000551753,0.001267887,0.00134728,0.0002002549,0.001164257,0.0009473969,0.0009885945,0.003994262],"category_scores_gemma":[0.001950304,0.0001851375,0.0007407138,0.001353112,0.0003988181,0.001375132,0.0005691577,0.001905482,0.0007662172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006414565,"about_ca_system_score_gemma":0.001366896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009878239,"about_ca_topic_score_gemma":0.002686879,"domain_scores_codex":[0.9997017,0.00008765691,0.00005751083,0.00004109329,0.00009003755,0.00002183822],"domain_scores_gemma":[0.9987999,0.0008610353,0.0001529911,0.00001448217,0.0001290218,0.00004247251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001126027,0.00005420166,0.000201006,0.02024562,0.0001778959,0.0001096099,0.00003899222,0.0004023977,0.00036011,0.003752015,0.02886107,0.9456845],"study_design_scores_gemma":[0.00009157696,0.0001380269,0.0011693,0.02569664,0.0006754977,0.001103696,0.0001167974,0.0002842879,0.0002461656,0.004628961,0.9658188,0.00003029649],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005208862,0.9988831,0.00006632043,0.0005316714,0.0001143949,0.000002491628,0.000011008,0.00000239559,0.0003365459],"genre_scores_gemma":[0.0006476267,0.9985134,0.0001634567,0.0003500698,0.0001838918,0.000003735983,0.00001805526,5.803556e-7,0.0001191729],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003994262,"threshold_uncertainty_score":0.01336211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282946191","doi":"10.1007/s11899-022-00663-7","title":"Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Canadian Institutes of Health Research","keywords":"CHEK2; Germline; Myeloid leukemia; Myeloid; Germline mutation; Biology; Chronic lymphocytic leukemia; Leukemia; Cancer research; Immunology; Genetics; Mutation; Gene","authors":[{"name":"Ryan J. Stubbins","is_ca":true},{"name":"Sophia C. Korotev","is_ca":false},{"name":"Lucy A. Godley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0919673839579153,"gpt":0.3717642047439677,"spread":0.2797968207860523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003158721,0.0004734602,0.0007559378,0.00208251,0.0001314048,0.0006086088,0.0005402265,0.0005251794,0.00302833],"category_scores_gemma":[0.0008927831,0.0001599581,0.0003675876,0.001907508,0.0002723231,0.0006503059,0.0004350767,0.0007495529,0.0007017723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003161595,"about_ca_system_score_gemma":0.000811086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00102511,"about_ca_topic_score_gemma":0.001799564,"domain_scores_codex":[0.9998478,0.00001918179,0.00003230798,0.00004026211,0.00004706148,0.00001335698],"domain_scores_gemma":[0.9997187,0.0001532102,0.00005458137,0.00000710898,0.00004684514,0.00001950882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008329175,0.0000218352,0.001218,0.01018854,0.0001688645,0.0006783762,0.00003516679,0.0002151348,0.001340041,0.001046008,0.0273895,0.9576151],"study_design_scores_gemma":[0.00005770164,0.00009185344,0.005773616,0.009134565,0.00131094,0.01157242,0.0001093092,0.0001489297,0.001092013,0.001706507,0.9689656,0.00003648928],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003218461,0.9980881,0.000129886,0.0002597125,0.0001807388,0.000002861456,0.00004149463,0.000008366671,0.0009670078],"genre_scores_gemma":[0.002630807,0.9958466,0.0002346554,0.0003361592,0.0002770971,0.000003291627,0.0001010777,0.000001735836,0.0005686304],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00302833,"threshold_uncertainty_score":0.01013076,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1944062703","doi":"10.1007/s11899-015-0287-9","title":"Social Media and Myeloproliferative Neoplasms (MPN)—Focus on Twitter and the Development of a Disease-specific Community: #MPNSM","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Texas MD Anderson Cancer Center; Incyte; National Cancer Institute; Gilead Sciences","keywords":"Social media; Medicine; Public relations; Citation; Focus group; Health care; Internet privacy; Political science; World Wide Web; Business; Computer science; Marketing","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Michael A. Thompson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1813166460235479,"gpt":0.373956349976804,"spread":0.1926397039532561,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004573429,0.0004168907,0.0006325247,0.001886258,0.0002709205,0.001107461,0.0003948399,0.0008813496,0.005066883],"category_scores_gemma":[0.001302152,0.0001567945,0.0005818321,0.00202178,0.0003262516,0.001425842,0.0007500713,0.0009108038,0.000924364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004241556,"about_ca_system_score_gemma":0.001020452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001758023,"about_ca_topic_score_gemma":0.004487831,"domain_scores_codex":[0.9997926,0.00005184491,0.00003962279,0.00003173196,0.0000646168,0.00001959474],"domain_scores_gemma":[0.9991252,0.0005269367,0.0001801417,0.00001008133,0.0001031718,0.00005461445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006948235,0.00004773425,0.002446006,0.02707599,0.0001806315,0.0001718672,0.0002025662,0.00009154559,0.0004188607,0.002898962,0.02867826,0.937718],"study_design_scores_gemma":[0.00002210349,0.0001031927,0.009557833,0.02454541,0.0004888448,0.001809657,0.0004820901,0.000108828,0.0002906556,0.001674592,0.9608822,0.0000346415],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004139363,0.9972133,0.00004368696,0.0007751904,0.000258837,0.000006158901,0.00005714816,0.000004046454,0.001227738],"genre_scores_gemma":[0.002837016,0.9958509,0.0001110376,0.0003462765,0.0003290392,0.000006604068,0.00005491539,0.000001060975,0.0004631209],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005066883,"threshold_uncertainty_score":0.01695037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766413477","doi":"10.1007/s11899-017-0421-y","title":"Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Social media; Social media analytics; Internet privacy; Field (mathematics); Health care; Categorization; Order (exchange); Analytics; Public relations; Medicine; Computer science; World Wide Web; Data science; Political science; Business","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Audun Utengen","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Michael A. Thompson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.414261216503102,"gpt":0.4844890275513483,"spread":0.07022781104824621,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.001242421,0.000638946,0.0008033817,0.004744601,0.0002991576,0.001291533,0.0005819599,0.0007668019,0.00210287],"category_scores_gemma":[0.005644252,0.000181235,0.001701766,0.005830207,0.0002109553,0.001751265,0.001017439,0.0007864093,0.000487236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005830939,"about_ca_system_score_gemma":0.001259963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004892983,"about_ca_topic_score_gemma":0.01498209,"domain_scores_codex":[0.9991541,0.0001886577,0.0001970088,0.0001340791,0.0002555959,0.00007052131],"domain_scores_gemma":[0.9963599,0.001491153,0.001351981,0.00006884515,0.0005386691,0.0001893963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003569913,0.0001265243,0.2541116,0.02853648,0.002567457,0.0003245666,0.001418967,0.000412021,0.000625441,0.001421889,0.02549422,0.6846038],"study_design_scores_gemma":[0.00006554258,0.0004188287,0.6811796,0.03246514,0.006022279,0.002543056,0.004669338,0.001651386,0.001080828,0.001711159,0.2679838,0.0002089905],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09227587,0.8820038,0.001070725,0.003331926,0.0008588084,0.0001867074,0.01488949,0.0000671712,0.005315471],"genre_scores_gemma":[0.2877806,0.6917037,0.003767584,0.001527675,0.001568449,0.0003676491,0.01062092,0.00003857419,0.002624758],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9952554,"threshold_uncertainty_score":0.009728968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2483061118","doi":"10.1007/s11899-016-0341-2","title":"Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM","year":2016,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AOP Orphan","keywords":"Social media; Hematologic Neoplasms; Social media analytics; Myeloproliferative neoplasm; Health care; Medicine; Public relations; Interpersonal communication; Internet privacy; Internal medicine; Political science; World Wide Web; Computer science; Sociology; Myelofibrosis; Social science; Cancer","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Audun Utengen","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Michael A. Thompson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06264256132008802,"gpt":0.3193700999007866,"spread":0.2567275385806985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001047814,0.0003933873,0.0003441433,0.00448513,0.0005356215,0.001591521,0.0004191036,0.0006923163,0.002629803],"category_scores_gemma":[0.008709104,0.0001129462,0.0004584003,0.003929595,0.0002404449,0.002087989,0.001262599,0.0005774395,0.001431582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004686337,"about_ca_system_score_gemma":0.000404737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005274445,"about_ca_topic_score_gemma":0.009917025,"domain_scores_codex":[0.9987413,0.0002768078,0.0001771741,0.0001391161,0.0004967325,0.0001688507],"domain_scores_gemma":[0.9880734,0.002836881,0.004933334,0.0003840284,0.00224286,0.001529501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000117987,0.00006802753,0.9727291,0.0001111777,0.0001105801,0.00007940242,0.0003750489,0.0002143829,0.000363296,0.0001687618,0.004548531,0.02111368],"study_design_scores_gemma":[0.000003344891,0.0001144452,0.9894565,0.00003786029,0.00004925172,0.0003378557,0.001231776,0.001927596,0.0002769867,0.0001193784,0.00642568,0.00001934963],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9658153,0.0009515323,0.0004896175,0.000822467,0.0001378223,0.00008691561,0.02615362,0.0001456046,0.005397138],"genre_scores_gemma":[0.9754284,0.0005279033,0.001187161,0.0001190015,0.0003106445,0.0001127451,0.01969111,0.00004109674,0.002582018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005274445,"threshold_uncertainty_score":0.0104875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2595388903","doi":"10.1007/s11899-017-0368-z","title":"Current Review on High-Risk Multiple Myeloma","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Risk stratification; Disease; Intensive care medicine; Hematology; Internal medicine; Oncology; Risk assessment","authors":[{"name":"Henry Chan","is_ca":true},{"name":"Christine I. Chen","is_ca":true},{"name":"Donna Reece","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1741396546027891,"gpt":0.4409754810943322,"spread":0.2668358264915431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005115613,0.0006814838,0.00156417,0.003146886,0.0002636324,0.001391265,0.000744214,0.0009709081,0.006961814],"category_scores_gemma":[0.002352749,0.0002877081,0.0009170718,0.003598057,0.0003184309,0.001358228,0.0007937131,0.001234037,0.001185582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005117409,"about_ca_system_score_gemma":0.00208299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001428856,"about_ca_topic_score_gemma":0.003113339,"domain_scores_codex":[0.9996438,0.00006278968,0.0001143235,0.000056046,0.00009954244,0.00002359266],"domain_scores_gemma":[0.9990569,0.0005317482,0.0002052807,0.00001568274,0.0001458308,0.00004461212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001171603,0.00006154124,0.0007146964,0.09153453,0.0004366652,0.0002515567,0.0001031319,0.0002154013,0.0005114271,0.001547941,0.06632838,0.8381774],"study_design_scores_gemma":[0.00005152067,0.00008104905,0.002176779,0.03335739,0.001427498,0.001782984,0.0001230023,0.00007949545,0.0001988333,0.001469488,0.9592175,0.00003441889],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006483823,0.9987683,0.00004694364,0.0002533052,0.0002204976,0.000005520981,0.0000428398,0.000005260591,0.000592499],"genre_scores_gemma":[0.000445602,0.9985659,0.0001270655,0.0003417238,0.0002694143,0.000005243893,0.00005088412,9.227483e-7,0.0001933552],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006961814,"threshold_uncertainty_score":0.02328962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008063389","doi":"10.1007/s11899-020-00560-x","title":"Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia","year":2020,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Chronic myelogenous leukemia; Medicine; Tyrosine kinase; Hematology; Dasatinib; Toxicity; Internal medicine; Tyrosine-kinase inhibitor; breakpoint cluster region; Imatinib; Leukemia; Cancer research; Pharmacology; Oncology; Receptor; Myeloid leukemia; Cancer","authors":[{"name":"Dakota Gustafson","is_ca":true},{"name":"Jason E. Fish","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true},{"name":"Nazanin Aghel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04617367194453772,"gpt":0.3129403496724175,"spread":0.2667666777278798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003690216,0.0006099388,0.001085086,0.001743865,0.0001814821,0.0007365163,0.0005546433,0.0005958146,0.003186548],"category_scores_gemma":[0.000885251,0.0001545693,0.0004808636,0.00152387,0.0002354586,0.0007566812,0.0004320897,0.0007938044,0.0008151105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003489594,"about_ca_system_score_gemma":0.001046789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007312078,"about_ca_topic_score_gemma":0.001211935,"domain_scores_codex":[0.9998475,0.00002912653,0.00003385956,0.00002190311,0.00005642111,0.00001117411],"domain_scores_gemma":[0.999652,0.000167066,0.00008666021,0.000005694962,0.0000687979,0.00001976397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009174694,0.00004213773,0.0002651011,0.06672481,0.0002014288,0.0002269325,0.00007809173,0.0003179007,0.001220496,0.001992366,0.0325148,0.8963242],"study_design_scores_gemma":[0.00002881379,0.0001719301,0.001820108,0.01944557,0.0004896774,0.002144615,0.0001052218,0.00009719471,0.0005296491,0.001507014,0.9736376,0.00002233562],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001000206,0.9991872,0.00003765403,0.0001358954,0.0001364768,0.000004221745,0.00001668152,0.000003500824,0.0003784707],"genre_scores_gemma":[0.0004702863,0.9990632,0.00004866732,0.0001177913,0.0001164041,0.000003172694,0.00001671317,5.448034e-7,0.0001632042],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003186548,"threshold_uncertainty_score":0.01066011,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014255239","doi":"10.1007/s11899-009-0030-5","title":"Update on the World Health Organization classification of peripheral T-cell lymphomas","year":2009,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Lymphoproliferative disorders; Hematology; Medicine; Phenotype; Pathology; Not Otherwise Specified; Oncology; Peripheral T-cell lymphoma; Internal medicine; T cell; Immunology; Biology; Gene; Genetics; Immune system","authors":[{"name":"Hilary M O'Leary","is_ca":true},{"name":"Kerry J. Savage","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07503516850817778,"gpt":0.3591512926496702,"spread":0.2841161241414924,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072059,0.0009619005,0.002249784,0.007846325,0.0003740143,0.001263183,0.001442011,0.001016664,0.004609727],"category_scores_gemma":[0.002440778,0.000366604,0.0009607638,0.005947657,0.0005128703,0.001956271,0.0007997669,0.001696054,0.003429198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001209092,"about_ca_system_score_gemma":0.003094926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004547519,"about_ca_topic_score_gemma":0.01294767,"domain_scores_codex":[0.9993359,0.0001062221,0.0002020782,0.00005871683,0.0002484896,0.00004849151],"domain_scores_gemma":[0.9980243,0.0005175592,0.0003794336,0.00004409677,0.0008737892,0.0001608558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007749292,0.00005746551,0.0006697317,0.009393184,0.0001040797,0.0004867484,0.00005590929,0.000154744,0.0007598063,0.0007829367,0.2852532,0.7022046],"study_design_scores_gemma":[0.00002964134,0.00004655279,0.002252514,0.00440018,0.0002494286,0.003136637,0.00006080106,0.00005857053,0.0001460072,0.0004625479,0.9891338,0.00002328333],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002800574,0.9917197,0.000301895,0.001821015,0.003236358,0.00002049091,0.0002675272,0.0000429484,0.002309961],"genre_scores_gemma":[0.001060503,0.9899302,0.001343747,0.002047637,0.002865734,0.00001999465,0.0007281359,0.000007775821,0.001996422],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007846325,"threshold_uncertainty_score":0.01542109,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062299904","doi":"10.1007/s11899-011-0100-3","title":"Update: Peripheral T-Cell Lymphomas","year":2011,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Hematology; Peripheral T-cell lymphoma; Oncology; Internal medicine; Disease; T-cell lymphoma; Peripheral; T cell; Pathology; Immunology; Immune system","authors":[{"name":"Kerry J. Savage","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07608571854870042,"gpt":0.3457742507995178,"spread":0.2696885322508173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007827806,0.001236755,0.002430061,0.00566961,0.0003293231,0.001511677,0.001172595,0.001378865,0.00805358],"category_scores_gemma":[0.002338785,0.0004473374,0.0006654673,0.004897556,0.0004467742,0.002394881,0.001124831,0.001784146,0.004293992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008136259,"about_ca_system_score_gemma":0.001988089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001546295,"about_ca_topic_score_gemma":0.005467221,"domain_scores_codex":[0.9995213,0.00008133569,0.000131186,0.00005337198,0.0001644534,0.00004844989],"domain_scores_gemma":[0.9984955,0.0004961747,0.0003673015,0.00003744371,0.0004488,0.0001547916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001047695,0.00005607365,0.000413601,0.01833121,0.0001356682,0.0005234973,0.00003728623,0.0002322423,0.0008836473,0.0003137303,0.2810019,0.6979665],"study_design_scores_gemma":[0.00004181209,0.00008494557,0.001404013,0.006913182,0.0004970236,0.003306215,0.00005415621,0.00007050648,0.0002290599,0.0002980592,0.9870781,0.00002292106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001643798,0.9935285,0.0001388786,0.00107203,0.003101753,0.00001522041,0.0001213404,0.00003537086,0.001822373],"genre_scores_gemma":[0.0007791205,0.9915214,0.0003461574,0.001838697,0.003344695,0.00001459182,0.0002441018,0.000005226836,0.001906144],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00805358,"threshold_uncertainty_score":0.0269419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2913763056","doi":"10.1007/s11899-019-0498-6","title":"Industry’s Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy","year":2019,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"NIH Clinical Center; Novartis Pharmaceuticals Corporation; University of Pennsylvania","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; Hematology; Cytokine release syndrome; Internal medicine; Clinical trial; Oncology; Cancer","authors":[{"name":"Stacie Ittershagen","is_ca":false},{"name":"Solveig G. Ericson","is_ca":false},{"name":"Lamis Eldjerou","is_ca":false},{"name":"Ali Shojaee","is_ca":false},{"name":"Eric Bleickardt","is_ca":false},{"name":"Manisha Patel","is_ca":false},{"name":"Tetiana Taran","is_ca":false},{"name":"Oezlem Anak","is_ca":false},{"name":"Charlene Hall","is_ca":false},{"name":"Mimi Leung","is_ca":false},{"name":"Deborah Roccoberton","is_ca":false},{"name":"Florence Salmon","is_ca":false},{"name":"Miriam Fuchs","is_ca":false},{"name":"Vadim Romanov","is_ca":false},{"name":"David Lebwohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09754620024724776,"gpt":0.3758267022807195,"spread":0.2782805020334717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009058719,0.0006090823,0.0009170316,0.001879032,0.0002374068,0.001210035,0.0005870937,0.001224018,0.003722099],"category_scores_gemma":[0.001319387,0.0002106254,0.0006642105,0.001611103,0.0004749858,0.00145928,0.0007112083,0.00207705,0.001779474],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000645876,"about_ca_system_score_gemma":0.001711471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009253407,"about_ca_topic_score_gemma":0.001245426,"domain_scores_codex":[0.9996026,0.00009018898,0.00004470558,0.00006076962,0.0001566736,0.00004501872],"domain_scores_gemma":[0.9994006,0.0003099338,0.00007611976,0.0000169209,0.0001571263,0.0000392967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008290498,0.00005304264,0.0001361441,0.03239457,0.0001186953,0.0002052394,0.0000908441,0.0004799875,0.002859608,0.009821719,0.0557327,0.8980246],"study_design_scores_gemma":[0.00001301904,0.00005859874,0.0002105172,0.003816121,0.00008614944,0.000449374,0.00004335718,0.00005540795,0.0005714915,0.001416546,0.9932702,0.000009231742],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001032754,0.9978173,0.0001315782,0.0005760335,0.0004340711,0.000004754448,0.00001396716,0.000008661808,0.000910276],"genre_scores_gemma":[0.001060834,0.9972542,0.0001785065,0.000647438,0.0002757985,0.000007316799,0.00002469142,0.000002572507,0.0005485247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003722099,"threshold_uncertainty_score":0.01245165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017131345","doi":"10.1007/s11899-012-0139-9","title":"“Antivirals” in the Treatment of Adult T Cell Leukaemia– Lymphoma (ATLL)","year":2012,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Zidovudine; Lymphoma; Oncology; Immunology; Hematology; Virus; Gastroenterology; Viral disease","authors":[{"name":"Paul Fields","is_ca":true},{"name":"Graham P. Taylor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06301480317142466,"gpt":0.312394578702239,"spread":0.2493797755308143,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005015368,0.0006798581,0.001364073,0.001402083,0.0002114581,0.0006369287,0.0008880047,0.0007853568,0.001816249],"category_scores_gemma":[0.0005821746,0.0002265426,0.0004924874,0.001285839,0.0004132901,0.0008263203,0.0004442982,0.001765813,0.0009653805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003459166,"about_ca_system_score_gemma":0.0006120623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007706728,"about_ca_topic_score_gemma":0.001853477,"domain_scores_codex":[0.9998245,0.00003145022,0.00003909678,0.00003160844,0.00005560446,0.00001772773],"domain_scores_gemma":[0.999737,0.0001386985,0.00004956485,0.000007391121,0.00004592922,0.00002141808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001310902,0.00007468618,0.0001641959,0.009501751,0.00008900605,0.0001863841,0.00002794494,0.0002117343,0.001608708,0.001048358,0.01447793,0.9724783],"study_design_scores_gemma":[0.0001345596,0.0003878573,0.001916817,0.005230765,0.0004810505,0.003300881,0.0000718138,0.0001706308,0.001604813,0.001518305,0.9851479,0.00003465827],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001530617,0.999118,0.00009068479,0.000134487,0.0001298946,0.000003402471,0.00001118996,0.00000490406,0.0003543738],"genre_scores_gemma":[0.001121443,0.9979218,0.0002310532,0.000238122,0.0001742673,0.000005655579,0.00003175796,0.000001195625,0.0002746972],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001816249,"threshold_uncertainty_score":0.006075919,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2482129219","doi":"10.1007/s11899-016-0340-3","title":"Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; European Hematology Association","keywords":"Social media; Hematology; The Internet; Hematologic malignancy; Medicine; Cancer; Internal medicine; Family medicine; Computer science; World Wide Web","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Michael A. Thompson","is_ca":false},{"name":"Andrew A. Lane","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04298612721636083,"gpt":0.3379909896827433,"spread":0.2950048624663825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002269507,0.0002586858,0.0006190594,0.001251786,0.0002347038,0.0005293256,0.0003444747,0.0005049793,0.003383323],"category_scores_gemma":[0.001054765,0.000104016,0.0006883931,0.001053046,0.0001586182,0.0006430096,0.0004175647,0.0005616305,0.0003266979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000210654,"about_ca_system_score_gemma":0.0004428778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001378668,"about_ca_topic_score_gemma":0.003994752,"domain_scores_codex":[0.9998716,0.00003704365,0.00002634309,0.0000194007,0.00003146169,0.00001411442],"domain_scores_gemma":[0.9995891,0.0002560414,0.00009349985,0.000006478667,0.00002955518,0.00002529874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002560689,0.0001673484,0.00885077,0.02075797,0.0004396513,0.0005854564,0.0001419712,0.00006394301,0.0005765397,0.0003977811,0.01512311,0.9526394],"study_design_scores_gemma":[0.0005099403,0.001063772,0.1011405,0.06163138,0.007270986,0.01695709,0.00180824,0.0004705646,0.001814571,0.001751369,0.8054568,0.0001248084],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004139728,0.9932418,0.0000650738,0.0005913862,0.0001449532,0.00001681523,0.0001140074,0.000007014732,0.001679188],"genre_scores_gemma":[0.03254465,0.9645282,0.0003465117,0.001035364,0.0003763251,0.00004231389,0.0002304379,0.000002591889,0.0008935918],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003383323,"threshold_uncertainty_score":0.01131827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593332867","doi":"10.1007/s11899-017-0372-3","title":"New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ponatinib; Medicine; Blinatumomab; Internal medicine; Oncology; Philadelphia chromosome; Dasatinib; Imatinib; Hematology; Chemotherapy; Lymphoblastic Leukemia; Leukemia; Chromosomal translocation; Myeloid leukemia","authors":[{"name":"Lalit Saini","is_ca":true},{"name":"Joseph Brandwein","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1141424554496944,"gpt":0.400997813282527,"spread":0.2868553578328326,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347907,0.0005521362,0.001176436,0.001470989,0.0002221631,0.0007642013,0.0008038228,0.0006643318,0.004436472],"category_scores_gemma":[0.001033406,0.000213567,0.0006799896,0.001145987,0.0003083586,0.001061707,0.0005193871,0.001551767,0.0009759166],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003928881,"about_ca_system_score_gemma":0.000781912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008567484,"about_ca_topic_score_gemma":0.002280351,"domain_scores_codex":[0.9998385,0.00003247511,0.00003757365,0.00002937538,0.0000464531,0.00001561335],"domain_scores_gemma":[0.999708,0.0001709484,0.00005394624,0.000006834603,0.00004499312,0.00001519599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008396575,0.00005829988,0.0002341033,0.01926705,0.0001272295,0.0001427646,0.00003500307,0.0002788,0.0006759193,0.002075572,0.02621766,0.9508037],"study_design_scores_gemma":[0.00008623094,0.000173144,0.001209083,0.01046225,0.0006517491,0.001634955,0.00007823969,0.0001482814,0.0004729714,0.002264254,0.9827947,0.00002408203],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009189591,0.9987565,0.00008955441,0.0002432689,0.0001458789,0.000004729645,0.00002167965,0.000005159249,0.0006412232],"genre_scores_gemma":[0.0008270991,0.9980732,0.0001921555,0.0004145517,0.0001541548,0.000007035791,0.00004500736,0.00000140907,0.0002853976],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004436472,"threshold_uncertainty_score":0.01484144,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2767073213","doi":"10.1007/s11899-017-0422-x","title":"Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":15,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Context (archaeology); Medicine; Disease; Cancer; Family medicine; Internal medicine; Computer science; World Wide Web; Biology","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Audun Utengen","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Michael A. Thompson","is_ca":false},{"name":"Andrew A. Lane","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4136773431322619,"gpt":0.4797684941524499,"spread":0.06609115102018803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.0008845027,0.0005559286,0.0006201078,0.004420414,0.0002837797,0.001021464,0.0004390822,0.0006062406,0.002251838],"category_scores_gemma":[0.003916635,0.0001358683,0.001050691,0.00479975,0.0001459557,0.001332323,0.0007417434,0.0004659791,0.0006171506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003575536,"about_ca_system_score_gemma":0.0007263702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003263118,"about_ca_topic_score_gemma":0.009815395,"domain_scores_codex":[0.9994253,0.0001177343,0.000122884,0.0001105126,0.0001703257,0.00005325755],"domain_scores_gemma":[0.9976773,0.0009189617,0.0007322522,0.00005978557,0.0004881825,0.0001235351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0005024523,0.0001308026,0.3225746,0.02353556,0.002587703,0.0003753703,0.001507588,0.0007559751,0.001739728,0.001763655,0.03915982,0.6053667],"study_design_scores_gemma":[0.00006406129,0.0004649074,0.738115,0.0108557,0.005337825,0.002445466,0.004119134,0.004021605,0.002187912,0.002117899,0.2300558,0.0002147358],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3208824,0.5959548,0.003563207,0.005092724,0.001724533,0.0003750212,0.05670783,0.0002703687,0.01542912],"genre_scores_gemma":[0.6972977,0.2607689,0.005701618,0.001316158,0.001797831,0.0004938202,0.02728557,0.00006271631,0.005275723],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9955796,"threshold_uncertainty_score":0.007533133,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2895867440","doi":"10.1007/s11899-018-0490-6","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN—Increasing Exposure over Two Years Since Inception of a Disease-Specific Twitter Community","year":2018,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; European Hematology Association","keywords":"Social media; Disease; Medicine; Health care; Order (exchange); Political science; Internal medicine; Computer science; Business; World Wide Web","authors":[{"name":"Naveen Pemmaraju","is_ca":false},{"name":"Audun Utengen","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Michael A. Thompson","is_ca":false},{"name":"Andrew A. Lane","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09026787319341162,"gpt":0.349614018565047,"spread":0.2593461453716354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003178168,0.0002763776,0.0004170161,0.001590167,0.0002299516,0.0007997174,0.0003114191,0.0005388953,0.002897985],"category_scores_gemma":[0.001248433,0.0001142238,0.0004546428,0.001874707,0.0002212659,0.0008955922,0.0004793086,0.0005751594,0.0005655918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000302758,"about_ca_system_score_gemma":0.0007657252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002960283,"about_ca_topic_score_gemma":0.008112376,"domain_scores_codex":[0.9997793,0.00004173602,0.00004771951,0.00004541316,0.00005935019,0.00002655414],"domain_scores_gemma":[0.9994074,0.00028926,0.0001747668,0.00001199871,0.00008342249,0.0000332085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001165949,0.00004156955,0.02378598,0.02486752,0.0003488355,0.0006041606,0.0004069589,0.0001061611,0.0008503077,0.001322343,0.02453011,0.9230194],"study_design_scores_gemma":[0.00002607666,0.0001265475,0.06770856,0.02828407,0.001289218,0.009863672,0.001517656,0.0001196317,0.0009773498,0.000991736,0.8890361,0.00005937706],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004574505,0.9911222,0.0001285299,0.000784023,0.0002781145,0.00001737811,0.0005024475,0.00001211047,0.002580647],"genre_scores_gemma":[0.02047754,0.9767397,0.0002756081,0.0007341678,0.0002773623,0.00001696076,0.0005524073,0.000003809969,0.0009223667],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002960283,"threshold_uncertainty_score":0.009694695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2309364123","doi":"10.1007/s11899-016-0317-2","title":"Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults","year":2016,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Hematology; Chemotherapy; Hematopoietic cell; Transplantation; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Lymphoblastic Leukemia; Young adult; Acute lymphocytic leukemia; Leukemia; Intensive care medicine; Pediatrics; Haematopoiesis; Stem cell","authors":[{"name":"Craig D. Speziali","is_ca":true},{"name":"Kristjan Paulson","is_ca":true},{"name":"Matthew D. Seftel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03268983140793776,"gpt":0.3511645003849713,"spread":0.3184746689770336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004569013,0.0004155043,0.0008544734,0.001713797,0.0001679369,0.0007108885,0.0005245088,0.0004848096,0.002635627],"category_scores_gemma":[0.001362818,0.0001478161,0.0004238458,0.001755777,0.0003080736,0.0007695397,0.0004754413,0.0009305307,0.0005194506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003309872,"about_ca_system_score_gemma":0.001019439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008060886,"about_ca_topic_score_gemma":0.001929294,"domain_scores_codex":[0.9998111,0.00003520548,0.00005585159,0.00003132802,0.00005412806,0.0000124239],"domain_scores_gemma":[0.9995327,0.0002841815,0.0001046945,0.000009519898,0.00004417251,0.00002462905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009056147,0.00003890237,0.0007898275,0.02450811,0.0001494639,0.0002654849,0.00004477089,0.0001266509,0.000558406,0.0008575271,0.01874031,0.9538299],"study_design_scores_gemma":[0.0001223453,0.0001763769,0.004426843,0.02636049,0.001417656,0.005655874,0.0001586076,0.00008272706,0.0007056533,0.001438763,0.9594268,0.00002784934],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001278268,0.9991087,0.00003421921,0.000133396,0.0001036517,0.000002896566,0.00001401255,0.000002675283,0.0004727038],"genre_scores_gemma":[0.001072406,0.9982654,0.00008640163,0.0002562268,0.0001442443,0.000003254358,0.00002740087,7.429925e-7,0.0001440455],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002635627,"threshold_uncertainty_score":0.008817077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052924000","doi":"10.1007/s11899-007-0022-2","title":"Is BEACOPP better than ABVD?","year":2007,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Procarbazine; Medicine; Dacarbazine; Vincristine; Oncology; Vinblastine; Prednisone; Internal medicine; Cyclophosphamide; Chemotherapy","authors":[{"name":"Bruce D. Cheson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.143285634881988,"gpt":0.417138273985897,"spread":0.2738526391039091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008066641,0.0006066369,0.002135191,0.001699312,0.0002923546,0.00113723,0.0007618454,0.0009523827,0.005044668],"category_scores_gemma":[0.001655558,0.0002898202,0.0005579508,0.001872267,0.0005636112,0.001498865,0.0004470026,0.001990006,0.001684368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000641036,"about_ca_system_score_gemma":0.001194854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001073903,"about_ca_topic_score_gemma":0.003068121,"domain_scores_codex":[0.9997311,0.00005261975,0.00007439408,0.00004972141,0.00007066811,0.00002149574],"domain_scores_gemma":[0.999445,0.0002958573,0.0001289364,0.00001478743,0.00007333366,0.00004205062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001913468,0.00004463934,0.0003634194,0.01386658,0.0001669851,0.0002334261,0.00002621512,0.0001023105,0.000388974,0.001064908,0.03503837,0.9485129],"study_design_scores_gemma":[0.0001772989,0.0002288715,0.002359423,0.01064757,0.0008227745,0.002981896,0.00009378742,0.00005889128,0.0003999278,0.001527261,0.980678,0.00002438975],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007297996,0.9986602,0.00002795366,0.0004623093,0.0002436561,0.000002005339,0.00001037972,0.000002973137,0.0005175777],"genre_scores_gemma":[0.0007818118,0.9974003,0.0001023943,0.0008633236,0.0004706931,0.000004689399,0.00002605394,0.000001128065,0.0003497936],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005044668,"threshold_uncertainty_score":0.0168761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W818882356","doi":"10.1007/s11899-015-0272-3","title":"Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Flow cytometry; Bone marrow; Hematology; International Prognostic Scoring System; Internal medicine; Biopsy; Pathology; Cytology; Oncology; Immunology","authors":[{"name":"Anna Porwit","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1503424921814746,"gpt":0.4220731153203322,"spread":0.2717306231388577,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001508507,0.0005744701,0.001972682,0.002041385,0.0002174279,0.001335686,0.001364441,0.00122164,0.002498016],"category_scores_gemma":[0.004007395,0.0002129503,0.0008554897,0.001434509,0.0007262622,0.00153121,0.0005749919,0.001911797,0.001181981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005201138,"about_ca_system_score_gemma":0.001432754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001569662,"about_ca_topic_score_gemma":0.002284358,"domain_scores_codex":[0.999423,0.0001460019,0.0001018575,0.00009130866,0.000203094,0.00003474329],"domain_scores_gemma":[0.9977989,0.0014289,0.0002186208,0.00004929617,0.0004239476,0.00008038684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009663709,0.00004243013,0.001851014,0.009176891,0.0001389028,0.0002731027,0.00004237319,0.0001287975,0.000730205,0.001525857,0.02260133,0.9633925],"study_design_scores_gemma":[0.00009573488,0.000187856,0.007959182,0.02057388,0.0007982427,0.005401618,0.0002406522,0.0002090842,0.001047093,0.003333485,0.9600937,0.00005924505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001249082,0.9982705,0.0001420212,0.0007385045,0.0002264915,0.000003915236,0.00002091431,0.000007569591,0.0004651418],"genre_scores_gemma":[0.001441488,0.9961056,0.0005756064,0.001067065,0.0004803294,0.000007337179,0.00005492361,0.000002398773,0.0002652079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002498016,"threshold_uncertainty_score":0.008356631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766799159","doi":"10.1007/s11899-017-0424-8","title":"Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Dystopia; Hematology; Utopia; Internal medicine; Social media; Medicine; Political science; Law","authors":[{"name":"Aaron T. Gerds","is_ca":false},{"name":"Teresa M. Chan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5896881544385401,"gpt":0.5592891715628737,"spread":0.03039898287566634,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106912,0.000599565,0.001166319,0.00340827,0.0004668605,0.001902791,0.0005984138,0.001488599,0.004886222],"category_scores_gemma":[0.003471021,0.000212169,0.0009486045,0.003386404,0.000732047,0.00233769,0.001113409,0.001633395,0.0006082573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007805396,"about_ca_system_score_gemma":0.002384883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00237871,"about_ca_topic_score_gemma":0.006819061,"domain_scores_codex":[0.9994612,0.0001666917,0.0001003214,0.00006297405,0.000156061,0.0000527455],"domain_scores_gemma":[0.9976819,0.00168339,0.0003104746,0.00002421734,0.0001962096,0.0001037103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009436255,0.00005050777,0.001649756,0.04805657,0.0002986085,0.0001681917,0.000311934,0.00007523166,0.0002107282,0.0037469,0.02789068,0.9174465],"study_design_scores_gemma":[0.00006322414,0.000121542,0.008789822,0.1141709,0.001325124,0.002183585,0.001589817,0.000113594,0.0003329149,0.003536097,0.867713,0.00006032568],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002136414,0.9979779,0.0000229627,0.000976102,0.0002469981,0.000004610269,0.00002890231,0.000002511781,0.0005262929],"genre_scores_gemma":[0.002077243,0.9966732,0.00006407344,0.0005819131,0.0003752546,0.000006573244,0.00002587103,0.000001139239,0.0001947834],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004886222,"threshold_uncertainty_score":0.01634598,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008576749","doi":"10.1007/s11899-013-0183-0","title":"Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy","year":2013,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Columbia College","funders":"","keywords":"Multiple myeloma; Medicine; Bortezomib; Hematology; Internal medicine; Malignancy; Hematologic malignancy; Intensive care medicine; Clinical trial; Oncology","authors":[{"name":"Jordan M. Schecter","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07505719191943697,"gpt":0.3537867960608366,"spread":0.2787296041413996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009559168,0.0008355459,0.003021079,0.002609078,0.0003600791,0.001603627,0.001416295,0.001534575,0.001699098],"category_scores_gemma":[0.002422678,0.0003321996,0.0007379794,0.002200166,0.0006202757,0.001890246,0.000775619,0.002725545,0.0009012213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001189451,"about_ca_system_score_gemma":0.002428301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002495428,"about_ca_topic_score_gemma":0.004703858,"domain_scores_codex":[0.999505,0.00009663228,0.0001087518,0.00008300976,0.0001727047,0.00003392539],"domain_scores_gemma":[0.9989491,0.0005550259,0.0001954696,0.00001535612,0.0002255042,0.00005957532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008548622,0.0000902973,0.001780409,0.0148199,0.0002159661,0.0003707418,0.00005097907,0.0004742638,0.000666731,0.003167197,0.03717405,0.9411041],"study_design_scores_gemma":[0.00008859208,0.000169335,0.0100423,0.03488784,0.001237631,0.007929073,0.0004606108,0.0007272976,0.0009231167,0.01077569,0.9326544,0.0001041557],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001074437,0.997822,0.0002057176,0.00126113,0.0001593928,0.000004798075,0.0000203798,0.000006280518,0.000412859],"genre_scores_gemma":[0.001036109,0.9973155,0.0005190508,0.0005501924,0.0003943766,0.000007092256,0.00003802155,0.000001173081,0.0001384232],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003021079,"threshold_uncertainty_score":0.008630157,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4309706624","doi":"10.1007/s11899-022-00682-4","title":"The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma","year":2022,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Oncology; Nausea; Internal medicine; Vomiting","authors":[{"name":"Arleigh McCurdy","is_ca":true},{"name":"Alissa Visram","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07597734830097738,"gpt":0.3604607559086861,"spread":0.2844834076077087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000636932,0.0005721519,0.001483229,0.001842066,0.0001822519,0.0009340495,0.0007789929,0.0007120384,0.002738536],"category_scores_gemma":[0.0008718349,0.0002339711,0.0008135154,0.001795685,0.0002751487,0.0009562574,0.0004862336,0.001331074,0.0006820688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004449859,"about_ca_system_score_gemma":0.001028901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001288941,"about_ca_topic_score_gemma":0.002910509,"domain_scores_codex":[0.9998255,0.00003576142,0.00003990989,0.00002456401,0.00005876952,0.00001544372],"domain_scores_gemma":[0.999681,0.0001640592,0.00007264341,0.000006320774,0.00005677462,0.00001917172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002634963,0.0000640693,0.000249946,0.03130842,0.0004208591,0.0001514119,0.00004095499,0.0003141667,0.0009909475,0.001495839,0.01753145,0.9471686],"study_design_scores_gemma":[0.0002330526,0.000327828,0.002042448,0.01183123,0.001457774,0.001420792,0.00007920064,0.0002264546,0.0006991512,0.001476495,0.9801713,0.00003422241],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008192025,0.9995043,0.00002592471,0.000105355,0.00005730044,0.000002213476,0.00001129551,0.00000197191,0.0002096045],"genre_scores_gemma":[0.0006559629,0.9988906,0.00008190369,0.000131142,0.00006453653,0.000003100939,0.00002130833,4.965829e-7,0.0001510267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002738536,"threshold_uncertainty_score":0.009161294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045989969","doi":"10.1007/s11899-008-0030-x","title":"Novel therapies in peripheral T-cell lymphomas","year":2008,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hematology; Oncology; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Bioinformatics; T cell; Immunology; Biology; Immune system","authors":[{"name":"Hilary M O'Leary","is_ca":true},{"name":"Kerry J. Savage","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07527003511942738,"gpt":0.3469950288066572,"spread":0.2717249936872299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468419,0.0009160631,0.00211367,0.002001197,0.0002422998,0.0008893052,0.001109959,0.0009038114,0.003795694],"category_scores_gemma":[0.000710475,0.0003063976,0.0006320836,0.001659985,0.000434959,0.001220478,0.0005510279,0.001845715,0.002050272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004675107,"about_ca_system_score_gemma":0.0006997455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00062959,"about_ca_topic_score_gemma":0.001636156,"domain_scores_codex":[0.9998137,0.00003484851,0.0000365888,0.000034605,0.00006015997,0.00002000127],"domain_scores_gemma":[0.9996839,0.0001736649,0.00005580567,0.00001064309,0.00005403901,0.00002206523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001183998,0.0001019404,0.0001361224,0.01391247,0.0001129333,0.0002697168,0.00003011585,0.0003369592,0.001497099,0.0009296238,0.02048736,0.9620672],"study_design_scores_gemma":[0.0001470454,0.0002821839,0.001189307,0.005783947,0.000508317,0.002621182,0.00005849962,0.0001737813,0.000842276,0.001116041,0.9872532,0.00002427628],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001215962,0.9987133,0.0001212913,0.0001250796,0.0001755905,0.000006520238,0.00001376065,0.000008548218,0.0007144158],"genre_scores_gemma":[0.0007791148,0.9978816,0.0002867671,0.0002837762,0.0002055698,0.00001072349,0.00003787563,0.000001697526,0.0005128279],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003795694,"threshold_uncertainty_score":0.01269782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007505304","doi":"10.1007/s11899-014-0213-6","title":"Which Hodgkin’s Patients in the Unites States Should Be Treated with BEACOPP?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Georgetown Hospital","funders":"","keywords":"ABVD; Medicine; Procarbazine; Dacarbazine; Vinblastine; Oncology; Internal medicine; Hodgkin's lymphoma; Regimen; Vincristine; Chemotherapy; Cyclophosphamide","authors":[{"name":"Bruce D. Cheson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03486173526679406,"gpt":0.2923363232740295,"spread":0.2574745880072354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007561687,0.0001426614,0.0004267219,0.0007505543,0.001289666,0.001576001,0.000447552,0.001327958,0.006585568],"category_scores_gemma":[0.003425913,0.0002029566,0.0004531915,0.000832499,0.0007381418,0.001946292,0.0005328145,0.001627534,0.0006871105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001324497,"about_ca_system_score_gemma":0.004030642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01325321,"about_ca_topic_score_gemma":0.04210047,"domain_scores_codex":[0.9994592,0.0001439819,0.00008302417,0.00005109462,0.00009764937,0.0001650015],"domain_scores_gemma":[0.9986714,0.0002826075,0.0002268492,0.00003216639,0.0002546983,0.0005324009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00105597,0.0006525277,0.6770139,0.0005783917,0.0001315585,0.00528774,0.0008653578,0.0003621352,0.001747796,0.002593763,0.06517779,0.2445331],"study_design_scores_gemma":[0.0005575013,0.0008694416,0.7527898,0.005688132,0.0005581963,0.02119951,0.02044445,0.001012281,0.002098847,0.008267383,0.1864017,0.0001127094],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4795096,0.1352569,0.001480467,0.291688,0.003705037,0.0002406359,0.001258871,0.0001409983,0.08671963],"genre_scores_gemma":[0.8916729,0.06331573,0.002739703,0.032517,0.003740344,0.0001031797,0.0009057396,0.00005325315,0.004952205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01325321,"threshold_uncertainty_score":0.02635217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415987224","doi":"10.1007/s11899-025-00764-z","title":"Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Ponatinib; Immunotherapy; Hematology; Minimal residual disease; Chemotherapy","authors":[{"name":"Tala Najdi","is_ca":false},{"name":"Sarah Khanfour","is_ca":false},{"name":"Fadi Haddad","is_ca":false},{"name":"Hampig Raphaël Kourié","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03765103770373049,"gpt":0.3498580066873185,"spread":0.312206968983588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468053,0.0007419452,0.001396557,0.001609743,0.0001727737,0.0009754638,0.0009036693,0.0009918171,0.002729622],"category_scores_gemma":[0.0006548139,0.0002216299,0.00045752,0.001864179,0.0004319279,0.0009485951,0.0005355855,0.002025249,0.00147534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005012531,"about_ca_system_score_gemma":0.0008697038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001089715,"about_ca_topic_score_gemma":0.002008271,"domain_scores_codex":[0.9998252,0.00003628067,0.00002059787,0.0000274209,0.00007038661,0.00002011729],"domain_scores_gemma":[0.9997512,0.0001252352,0.00004076463,0.000006210174,0.00005350536,0.00002311992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001265899,0.00009307167,0.0001055476,0.01439315,0.00008781698,0.0001276459,0.00003470595,0.0004422506,0.002123464,0.002950606,0.02705867,0.9524566],"study_design_scores_gemma":[0.00005843212,0.0001660072,0.0004715944,0.002830986,0.0001537276,0.0006571169,0.00003637192,0.0001154815,0.0005544287,0.001135704,0.9938058,0.0000143441],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006483946,0.9992436,0.00006746154,0.0001307302,0.0001336767,0.000003224081,0.000007905039,0.000003641514,0.0003448912],"genre_scores_gemma":[0.0003687852,0.9989728,0.00009861654,0.0001725258,0.0001069456,0.000003429695,0.00001569604,7.917043e-7,0.0002605229],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002729622,"threshold_uncertainty_score":0.009131491,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2191051211","doi":"10.1007/s11899-015-0296-8","title":"Myelofibrosis—When Do We Select Transplantation or Non-transplantation Therapeutic Options?","year":2015,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Transplantation; Ruxolitinib; Hematology; Internal medicine; Hematopoietic stem cell transplantation; Janus kinase; Oncology; Intensive care medicine; Disease; Bone marrow","authors":[{"name":"Auro Viswabandya","is_ca":true},{"name":"Rebecca Devlin","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1169405602821958,"gpt":0.3937964703190582,"spread":0.2768559100368624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008148238,0.0004480639,0.001407566,0.001825376,0.0002741725,0.001397047,0.00066884,0.0009232171,0.003027196],"category_scores_gemma":[0.003554839,0.0001827224,0.0004570305,0.001267948,0.0006073218,0.001893114,0.00046261,0.001754537,0.0007827911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005221116,"about_ca_system_score_gemma":0.00141265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009121334,"about_ca_topic_score_gemma":0.003037884,"domain_scores_codex":[0.9997116,0.00006879229,0.00008469194,0.00004365816,0.00007071176,0.0000205537],"domain_scores_gemma":[0.9986662,0.0007877675,0.000255332,0.000020372,0.000189573,0.00008079103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008330475,0.00004058644,0.001699312,0.009296516,0.0001482595,0.0004934501,0.00007437922,0.0002394734,0.0003287172,0.002932417,0.04487551,0.939788],"study_design_scores_gemma":[0.00009864736,0.0001235073,0.004574634,0.03792348,0.0009773105,0.009450073,0.000481582,0.0002460744,0.0003871163,0.006518564,0.9391658,0.00005329528],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002898827,0.9957861,0.0001725029,0.002241852,0.0004082804,0.000003765695,0.00002576283,0.000007180477,0.001064658],"genre_scores_gemma":[0.003910822,0.9912486,0.0006462571,0.002267645,0.001456466,0.000009746021,0.00006561706,0.000003107254,0.0003917264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003027196,"threshold_uncertainty_score":0.01012701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376641118","doi":"10.1007/s11899-023-00698-4","title":"A Pragmatic Approach to Managing Long-Term Adverse Effects in Chronic Myeloid Leukemia Treatment","year":2023,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Hematology; Oncology; Internal medicine; Population; Intensive care medicine","authors":[{"name":"Josephine Anne Lucero","is_ca":true},{"name":"Jeffrey H. Lipton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0647491682968343,"gpt":0.36325252237516,"spread":0.2985033540783257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001651505,0.0006156,0.001669141,0.001554905,0.0002485081,0.001365753,0.0008769789,0.001168729,0.004064015],"category_scores_gemma":[0.003312985,0.0002313837,0.001338316,0.001033866,0.0003940696,0.0010266,0.0006373361,0.002318999,0.0006287945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008151756,"about_ca_system_score_gemma":0.002088408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001586227,"about_ca_topic_score_gemma":0.004869767,"domain_scores_codex":[0.9992478,0.0002760006,0.0001767588,0.00006810106,0.0001991028,0.00003218858],"domain_scores_gemma":[0.9985129,0.001041485,0.0002300296,0.00001972333,0.0001565381,0.00003922546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00013057,0.00009334657,0.0002287228,0.05044293,0.0004268469,0.000119594,0.00007417395,0.0002977125,0.0004753511,0.00366635,0.0187311,0.9253134],"study_design_scores_gemma":[0.0003292483,0.0003410101,0.002523805,0.07863509,0.002008401,0.001393135,0.0001556262,0.0002911137,0.0003056786,0.004653778,0.9093158,0.00004725419],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009071747,0.9980599,0.0001639507,0.0006532699,0.0001699236,0.00001461029,0.00001656553,0.000005832431,0.000825159],"genre_scores_gemma":[0.001888837,0.9951355,0.0008184765,0.00147515,0.0002762533,0.0000233078,0.00003215537,0.000001594548,0.000348888],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004064015,"threshold_uncertainty_score":0.01359552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022946612","doi":"10.1007/s11899-014-0214-5","title":"Chemotherapy Only in Early Stage Hodgkin Lymphoma: More Relapses but the Same Survival – What to Do?","year":2014,"lang":"en","type":"article","venue":"Current Hematologic Malignancy Reports","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"ABVD; Medicine; Lymphoma; Stage (stratigraphy); Hodgkin's lymphoma; Chemotherapy; Radiation therapy; Hodgkin lymphoma; Internal medicine; Dacarbazine; Randomized controlled trial; Survival rate; Positron emission tomography; Oncology; Surgery; Radiology; Vincristine; Cyclophosphamide","authors":[{"name":"Joseph M. Connors","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02428622731474941,"gpt":0.3011997911824983,"spread":0.2769135638677489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008285268,0.0007216188,0.004901723,0.000950236,0.0008898761,0.003976683,0.002224559,0.004574513,0.00732901],"category_scores_gemma":[0.01984172,0.0005378592,0.001986593,0.001602676,0.001738422,0.008163674,0.0008646231,0.004652251,0.001993658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001665699,"about_ca_system_score_gemma":0.003284149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004276769,"about_ca_topic_score_gemma":0.01059188,"domain_scores_codex":[0.9963229,0.001420919,0.0008661264,0.0004700937,0.0005932094,0.0003267932],"domain_scores_gemma":[0.9706194,0.01967697,0.003521551,0.001217073,0.003124921,0.001840102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007222112,0.001832016,0.1442604,0.008443178,0.003189853,0.0008963774,0.0004962833,0.0009355987,0.002443216,0.002676526,0.07082906,0.7567753],"study_design_scores_gemma":[0.00882393,0.01496686,0.6053822,0.02579865,0.01987936,0.0104808,0.009357695,0.003377355,0.002723708,0.03187879,0.2663748,0.0009557932],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1200371,0.553103,0.001331666,0.3031347,0.01251777,0.0001712863,0.001463754,0.0001936324,0.008047043],"genre_scores_gemma":[0.4754482,0.3205945,0.004105119,0.1248962,0.06809547,0.0002594196,0.002263364,0.0002316001,0.004106199],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008285268,"threshold_uncertainty_score":0.04381722,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402312879","doi":"10.1007/s11899-024-00742-x","title":"Advances in Stem Cell Transplantation for Myelofibrosis","year":2024,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Transplantation; Hematology; Stem cell; Internal medicine; Oncology; Intensive care medicine; Biology; Bone marrow; Genetics","authors":[{"name":"Akhil Rajendra","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06258721104371225,"gpt":0.3826865452418554,"spread":0.3200993341981431,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008305158,0.000646768,0.00142657,0.002517067,0.0002409514,0.0009915309,0.0007974188,0.0007617616,0.003934792],"category_scores_gemma":[0.001314931,0.0002179709,0.0006219969,0.002149784,0.0004148568,0.00120243,0.0006365937,0.001744089,0.001371927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003701385,"about_ca_system_score_gemma":0.0009538871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006940223,"about_ca_topic_score_gemma":0.001417254,"domain_scores_codex":[0.9997916,0.00003844502,0.00004364184,0.00003625472,0.00007405152,0.00001616118],"domain_scores_gemma":[0.999375,0.000380974,0.00007891161,0.00001506926,0.0001136278,0.0000364659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007000956,0.00004782745,0.0001840724,0.01631323,0.00009752771,0.0001294171,0.00002833683,0.000221849,0.0007113888,0.001623912,0.01940385,0.9611685],"study_design_scores_gemma":[0.00006750095,0.0001778717,0.001345723,0.009486563,0.000497694,0.002034694,0.0000617007,0.0001613691,0.0005891214,0.002191086,0.9833564,0.00003031257],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004965124,0.999265,0.00007089924,0.0001252491,0.0001341976,0.000002249633,0.00001025187,0.000003422996,0.0003390658],"genre_scores_gemma":[0.0004258891,0.9987483,0.0001472648,0.0002225568,0.0002492679,0.000003293746,0.00002429107,0.00000119635,0.0001778952],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003934792,"threshold_uncertainty_score":0.01316321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413100643","doi":"10.1007/s11899-025-00754-1","title":"Allogeneic Transplant for CMML","year":2025,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Oncology; Intensive care medicine","authors":[{"name":"Nico Gagelmann","is_ca":false},{"name":"Nihar Desai","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09515401914913654,"gpt":0.4224962066267783,"spread":0.3273421874776418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005301218,0.000583336,0.0008913276,0.001012263,0.0001997962,0.0009971401,0.0005660373,0.0008094538,0.01522656],"category_scores_gemma":[0.001829798,0.0001224045,0.0007474063,0.0006984643,0.0002163076,0.0007126501,0.0005168617,0.001099683,0.005220846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004002934,"about_ca_system_score_gemma":0.000884605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003028677,"about_ca_topic_score_gemma":0.0004009133,"domain_scores_codex":[0.9997026,0.00006829313,0.00006766176,0.00004347024,0.00009455591,0.00002343152],"domain_scores_gemma":[0.9994305,0.000225446,0.0001695078,0.00001930085,0.00009957029,0.00005560111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002025027,0.00003893851,0.0006095035,0.02738153,0.0002684573,0.0006312287,0.00004245003,0.0001838291,0.0009176647,0.002225575,0.1519775,0.8155208],"study_design_scores_gemma":[0.00006778051,0.0001388582,0.001617746,0.02007727,0.00041406,0.006516368,0.00005224731,0.00007688709,0.000620398,0.001614838,0.9687838,0.00001976875],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006468918,0.9846588,0.0004412803,0.002091289,0.004793545,0.00005661136,0.0003005052,0.00005771229,0.006953416],"genre_scores_gemma":[0.004935275,0.9795364,0.0005347508,0.004072333,0.00712747,0.00005361409,0.0008255837,0.00003149866,0.002883044],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01522656,"threshold_uncertainty_score":0.05093783,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}